Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Healthcare Services Group
HCSG
$1.63B
| $12.8M | 0.01% |
+295,404
| New | +$11.7M |
|
|
APLS
452
DELISTED
Apellis Pharmaceuticals
APLS
| $12.6M | 0.01% |
570,464
+191,313
| +50% | +$4.4M |
|
|
EQM
453
DELISTED
EQM Midstream Partners, LP
EQM
| $12.5M | 0.01% |
242,875
-44,817
| -16% | -$2.53M |
|
|
NFX
454
DELISTED
Newfield Exploration
NFX
| $12.1M | 0.01% |
+398,820
| New | +$11.3M |
|
455
G-III Apparel Group
GIII
$1.55B
| $12.1M | 0.01% |
271,525
+255,925
| +1,641% | +$10.4M |
|
456
Sunrun
RUN
$2.3B
| $12M | 0.01% |
910,842
-207,347
| -19% | -$2.25M |
|
|
NUVA
457
DELISTED
NuVasive, Inc.
NUVA
| $11.6M | 0.01% |
223,235
+15,197
| +7% | +$796K |
|
|
AIMT
458
DELISTED
Aimmune Therapeutics
AIMT
| $11.6M | 0.01% |
429,534
+7,668
| +2% | +$235K |
|
|
IMGN
459
DELISTED
Immunogen Inc
IMGN
| $11.3M | 0.01% |
+1,164,643
| New | +$12.3M |
|
460
Reliance Steel & Aluminium
RS
$21.2B
| $11.3M | 0.01% |
129,246
-398,246
| -75% | -$36.2M |
|
461
AT&T
T
$169B
| $11.2M | 0.01% |
+460,118
| New | +$11.5M |
|
|
CIM
462
Chimera Investment
CIM
$1.06B
| $11M | 0.01% |
201,432
| – | – |
|
463
Warrior Met Coal
HCC
$4.17B
| $11M | 0.01% |
399,210
-136,307
| -25% | -$3.59M |
|
464
Select Water Solutions
WTTR
$2.24B
| $10.8M | 0.01% |
740,617
+177,241
| +31% | +$2.61M |
|
465
Wheaton Precious Metals
WPM
$49.8B
| $10.6M | 0.01% |
480,653
-28,518
| -6% | -$614K |
|
|
NSU
466
DELISTED
Nevsun Resources Ltd.
NSU
| $10.5M | 0.01% |
3,026,146
-288,446
| -9% | -$886K |
|
467
WSFS Financial
WSFS
$4.2B
| $10.3M | 0.01% |
192,473
+470
| +0.2% | +$24.4K |
|
|
KA
468
DELISTED
Kineta, Inc. Common Stock
KA
| $10.2M | 0.01% |
26,169
+299
| +1% | +$187K |
|
469
Adicet Bio
ACET
$76.7M
| $10.1M | 0.01% |
9,842
+2,560
| +35% | +$2.76M |
|
|
ANDX
470
DELISTED
Andeavor Logistics LP
ANDX
| $9.93M | 0.01% |
233,518
-274,567
| -54% | -$12.3M |
|
471
Repligen
RGEN
$8.2B
| $9.73M | 0.01% |
206,804
+182,562
| +753% | +$7.51M |
|
|
EVBG
472
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $9.68M | 0.01% |
+204,022
| New | +$8.68M |
|
|
DBD
473
DELISTED
Diebold Nixdorf Incorporated
DBD
| $9.61M | 0.01% |
804,554
-13,653
| -2% | -$183K |
|
474
iRhythm Holdings
IRTC
$3.86B
| $9.52M | 0.01% |
117,299
+5,262
| +5% | +$368K |
|
475
Lowe's Companies
LOW
$122B
| $9.41M | 0.01% |
+98,466
| New | +$8.91M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.